Chemed (FRA:CXM) YoY EBITDA Growth : 11.66% (As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Chemed YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Chemed's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 11.66%.

Chemed's EBITDA per Share for the three months ended in Mar. 2024 was €6.04.

Chemed YoY EBITDA Growth Historical Data

The historical data trend for Chemed's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chemed YoY EBITDA Growth Chart

Chemed Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

14.34

34.50

0.13

7.72

1.62

Chemed Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															-9.64	-18.26	8.38	27.70	11.66

Chemed YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Chemed's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(24.997	-	24.598)	/	\| 24.598 \|
=	1.62 %

Chemed's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(6.041	-	5.41)	/	\| 5.41 \|
=	11.66 %

Chemed YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Chemed's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Chemed (FRA:CXM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Chemed Corp (FRA:CXM) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

CHE:USA

Address

255 East Fifth Street, Suite 2600, Cincinnati, OH, USA, 45202-4726

Website

https://www.chemed.com

Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative-care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States.